Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg - Related Studies

Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg

This study has been completed.

Study NCT00649558. Last updated on March 31, 2008. Information provided by Mylan Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Healthy

2	Interventions listed in this trial
		Pioglitazone HCl Tablets 45 mg
		Actos® Tablets 45 mg

3	Additional drug interventions recognized in this trial
		Pioglitazone

4	More general drug interventions related to this trial
		Hypoglycemic Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

5	Sponsors listed in this trial
		Mylan Pharmaceuticals